Natural Products: Key Prototypes to Drug Discovery Against Neglected Diseases Caused by Trypanosomatids

Author:

Varela Marina Themoteo1,Fernandes João Paulo S.1

Affiliation:

1. Department of Pharmaceutical Sciences, Universidade Federal de São Paulo, Diadema-SP, Brazil

Abstract

Background: Neglected tropical diseases are a group of infections caused by microorganisms and viruses that affect mainly poor regions of the world. In addition, most available drugs are associated with long periods of treatment and high toxicity which limits the application and patient compliance. Investment in research and development is not seen as an attractive deal by the pharmaceutical industry since the final product must ideally be cheap, not returning the amount invested. Natural products have always been an important source for bioactive compounds and are advantageous over synthetic compounds when considering the unique structural variety and biological activities. On the other hand, isolation difficulties and low yields, environmental impact and high cost usually limit their application as drug per se. Objective: In this review, the use of natural products as prototypes for the semi-synthesis or total synthesis, as well as natural products as promising hits is covered, specifically regarding compounds with activities against trypanosomatids such as Trypanosoma spp. and Leishmania spp. Methods: Selected reports from literature with this approach were retrieved. Conclusion: As summary, it can be concluded that natural products are an underestimated source for designing novel agents against these parasites.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry

Reference57 articles.

1. Neglected tropical diseases. World Health Organization. Available at: ext-link-type="uri" xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.who.int/neglected_diseases/diseases/en/">http://www.who.int/neglected_diseases/ diseases/en/ (Accessed Date: November 26, 2017).

2. Aagaard-Hansen, J.; Chaignat, C.L. Neglected tropical diseases: equity and social determinants in: Equity, social determinants and public health programmes; Blas, E.; Kurup, A. S. K., Eds.; World Health Organization: Geneva, SWI, 2010, pp. 135-157.

3. Moran, M. Global funding of new products for neglected tropical diseases in: Institute of Medicine (US) Forum on Microbial Threats. The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies; National Academies Press: Washington (DC), US, 2011, A16.

4. Chapman N.; Abela-Oversteegen L.; Doubell A.; Chowdhary V.; Gurjav U.; Ong M.; Neglected disease research and development: a pivotal moment for global health Policy Cures 2016,115

5. Patwardhan B.; Ethnopharmacology and drug discovery. J Ethnopharmacol 2005,100(1-2),50-52

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3